The LSD1 inhibitor T-3775440 suppresses SCLC proliferation by disrupting the interaction between LSD1 and the SNAG-domain proteins insulinoma-associated protein 1 (INSM1) and growth-factor-independent 1B (GFI1B) (175). This evidence concerns the gene KDM1A and small cell lung carcinoma.